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The West Nile Virus (WNV) non-structural proteins 2B and 3 (NS2B–NS3) constitute the proteolytic complex that mediates the cleavage and
processing of the viral polyprotein. NS3 recruits NS2B and NS5 proteins to direct protease and replication activities. In an effort to investigate the
biology of the viral protease, we cloned cDNA encoding the NS2B–NS3 proteolytic complex from brain tissue of a WNV-infected dead crow,
collected from the Lower Merion area (Merion strain). Expression of the NS2B–NS3 gene cassette induced apoptosis within 48 h of transfection.
Electron microscopic analysis of NS2B–NS3-transfected cells revealed ultra-structural changes that are typical of apoptotic cells including
membrane blebbing, nuclear disintegration and cytoplasmic vacuolations. The role of NS3 or NS2B in contributing to host cell apoptosis was
examined. NS3 alone triggers the apoptotic pathways involving caspases-8 and -3. Experimental results from the use of caspase-specific inhibitors
and caspase-8 siRNA demonstrated that the activation of caspase-8 was essential to initiate apoptotic signaling in NS3-expressing cells.
Downstream of caspase-3 activation, we observed nuclear membrane ruptures and cleavage of the DNA-repair enzyme, PARP in NS3-expressing
cells. Nuclear herniations due to NS3 expression were absent in the cells treated with a caspase-3 inhibitor. Expression of protease and helicase
domains themselves was sufficient to trigger apoptosis generating insight into the apoptotic pathways triggered by NS3 from WNV.
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West Nile Virus (WNV) is a single stranded RNA virus
from the family of Flaviviridae that is mosquito-borne. Cross-
neutralization studies have shown that WNV is antigenically
related to the Japanese encephalitis virus sero complex
(Chambers et al., 1990a). The genome organization of WNV
encodes, as in other typical flaviviruses, three structural genes,
such as capsid, preM and envelope that are encoded in the 5V
quarter of the genome. The non-structural gene products are
arranged serially from NS1 through NS5 encoded at the C-
terminal end of the polyprotein. The seven non-structural
genes include, NS1, NS2A, NS2B, NS3, NS4A, NS4B and
NS5 (Chambers et al., 1990a). Host cell signalases and viral0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2005.08.043
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polyprotein precursor through the translocation channel of the
rough endoplasmic reticulum (Brinton, 2002; Chambers et al.,
1990a). Both the structural and non-structural genes are
flanked on either side by non-coding regions of 300–600 bp
in length (Chambers et al., 1990a).
WNV is a neurotropic virus that causes West Nile
encephalitis in humans and in a variety of animals and birds
(Kramer and Bernard, 2001). It can also cause a spectrum of
illness, which includes WN fever, chorioretinities, acute flaccid
paralysis syndrome and fatal meningoencephalitis. The clinical
manifestations of WNV infection are well defined but the
mechanism of pathogenesis of WNV has not been elucidated.
Previous studies have documented that WNV could infect and
induce CPE in various cell cultures of human, primate, rodent
and insect origin. Humans develop a febrile illness, with a
subset of cases progressing to meningoencephalitis (Sampson06) 56 – 72
www.e
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In humans, as well as in experimental animal studies of fatal
infection associated with WNV infection, the triggering of both
necrosis and apoptosis in WNV-infected cells and tissue was
observed. Recent reports provided ultra-structural evidence for
cytoplasmic vacuolations, membrane blebbing and chromatin
disintegrations in WNV-infected cells (Chu and Ng, 2003;
Parquet et al., 2001a). However, it is still uncertain which gene
products of WNV are responsible for these manifestations.
There are few reports available that describe the induction of
apoptotic pathways in the host cell by WNV infection. So far,
among the WNV genes, only capsid was reported to induce
apoptosis through a mitochondrial-based caspase-9 pathway
(Yang et al., 2002). However, it is highly likely, based on
homology with other flaviviruses that other WNV gene
products also could participate in the apoptotic process.
Recently, NS2B–NS3 (non-structural gene 2B –non-structural
gene 3) proteolytic complex (Shafee and AbuBakar, 2003) as
well as NS3 (Prikhod’ko et al., 2002) of Dengue and Langat
viruses, respectively, have been shown to induce apoptosis in
human cells. WNV NS3 shares a significant level of homology
with these flaviviruses. WNV NS3 possesses both proteolytic
and helicase activities, and such activities can be associated
with apoptotic induction. Thus, NS2B–NS3 appears to be a
likely proapoptotic complex in WNV whose biology should be
investigated in the context of host cell killing.
Flaviviral NS3 protein includes the domains which are
necessary to carry out protease, nucleoside triphosphatase
(NTPase) and helicase activities (Chambers et al., 1990b;
Lobigs, 1992; Preugschat et al., 1990; Pugachev et al., 1992,
1993; Wengler et al., 1991). During the flaviviral life cycle,
NS2B binds to NS3 in vivo in order to form a proteolytic-
complex, which is believed to be essential for proteolytic
processing of viral polyprotein (Falgout et al., 1991, 1993) that
is formed directly from the positively stranded RNA genome as
a single polyprotein. This is further cleaved into its individual
gene products by NS2B–NS3 complex (Chambers et al.,
1990b, 1991). Besides the reported role of this complex on the
proteolytic processing of viral proteins, physiological and
pathological relevance of this complex in WNV pathogenesis is
unclear. In the present study, we examined whether the NS2B–
NS3 complex could contribute to any of the pathological
manifestations that were described in WNV-infected cells. The
expression of WNV NS2B–NS3 proteolytic complex in the
absence of other viral antigens caused rapid cell death. Further,
we identify that only NS3 and not NS2B of NS2B–NS3
complex triggers apoptotic cell death. Furthermore, a deletion
mutagenesis approach led us to conclude that both the protease
and helicase domains in NS3 appear to contribute to the host
cell killing.
Results
Cloning and expression analysis of WNV NS2B–NS3 Complex
In WNV, the non-structural genes NS2B and NS3 are
arranged adjacently. In the present study, cDNA encodingWNVNS2B–NS3 complex was cloned into a mammalian expression
vector (Fig. 1A). A polyhistidine (6XHis) was fused at its C-
terminal end for immunodetection purposes. The cloned
sequence was verified with WNV entries contained in the
NCBI database (http://www.ncbi.nlm.nih.gov). The amino acid
sequence of the Merion strain (Ramanathan et al., in press)
NS2B–NS3 was aligned with NY-99 strain as well as other
related Flaviviral proteolytic complex that were earlier pub-
lished to induce apoptosis. The Merion strain NS2B–NS3
complex has a complete homology with NY-99 strain. With
Kunjin virus NS3, it has almost 95% homology. Next to this
Australian subtype virus, JEV NS3 shared 82% identity with the
Merion strain NS3. Dengue-2 (Shafee and AbuBakar, 2003),
TBE and Langat (Prikhod’ko et al., 2002) virus NS3 proteins
displayed 62%, 42% and 44% homology respectively with the
Merion NS3. We were interested to find whether WNV NS3
amino acid sequence shares any homology with any of the
mammalian and/or human proteins. A BLAST search against
the mammalian proteins revealed that WNV NS3 shares
homology with a few helicases of human and mouse origin.
In particular, a region spanning through 166–288 in WNV NS3
aligns with the human DEAD box protein-16 (DDX16; SP
060231) at its region of 392–523, and also with a mouse DEAD
box protein, DDX-36 (XP_227203.2) at its region ranging
between 190 and 329 (Fig. 1B). Prior to its use in the cell culture
studies, the integrity of this construct was confirmed in an in
vitro translation system to examine the encoded 35S-labeled
protein product. Autoradiographic analysis revealed that the
molecular weight of the complex is about 75 kDa (data not
shown). We examined the expression pattern of this viral gene
complex in the cells transfected with the pNS2B–NS3-
expression plasmid by indirect immunofluorescence. The
expression of the complex was observed in the cytoplasmic as
well as perinuclear regions of the cells. Also, typical membrane
blebbing and extensive cytoplasmic vacuolations were noted in
cells expressing the complex (Fig. 1C; a, b). A lack of any
staining pattern in the mock-transfected cells treated with the
same anti-His antibody (Fig. 1C; c, d) supports the specificity of
this assay as well as the localization of these WNV gene
products. The expression pattern of the complex was also
examined in other mammalian cells such as, HeLa, RD, NIH
3T3, SH-SY5Y (human glioblastoma cell line), LN-229 (human
brain microglial cells) and Vero cells (African green monkey
cells). Consistently, we observed an identical pattern of
expression in all of these cell lines tested (data not shown).
Expression of WNV NS2B–NS3 induces apoptosis in
mammalian cells
In order to study the effect of expression of NS2B–NS3
complex in human cells, in the absence of other WNVantigens,
we transfected RD cells with this gene cassette. In the similar
settings, pcDNA3.1-transfected and pBax-transfected cells
served as negative and positive controls, respectively. The
number of viable cells was significantly reduced in NS2B–
NS3-expressing cells, compared to the mock-transfected
sample. At 72 h after transfection, 42.3% of the cells were
Fig. 1. Cloning and expression of NS2B–NS3 complex. From the brain tissue of the WNV-infected dead crow, cDNA encoding WNV NS2B–NS3 was cloned in
pcDNA3.1/His vector to generate a fusion protein with His-tag at its C-terminus. Panel A shows the diagrammatic map of pcNS2B–NS3 and a gel picture indicating
a fragment size of 2250 bps digested from pcNS2B–NS3. (B) The deduced amino acid sequence of the cloned NS2B–NS3 complex. The positions of NS2B (131
residues) and NS3 (619 residues) are arrow-marked in NS2B–NS3 complex. The NS3 comes under the classification of Class II superfamily of helicases. The
conserved regions of the Class II family helicases are shown in boxes. Box 1 indicates homology between WNV NS3 and a human cellular protein, DEAD-box
protein (DDX-16). This region includes the conserved DEAD/H residues that are typical to DEAD-box proteins. The C-terminal region of NS3 displays a certain
degree of alignment with another human protein, called RNA-helicase (ATP-dependent RNA helicase-3) as outlined in Box B. The conserved regions of NS3 are
shown in bold letters. Below these bolded letters, the corresponding matching residues from human proteins were given in small cases. + indicates the maintenance
of ionic strength. Panel C shows the localization of NS2B–NS3 in Neuro-2a cells. Neuro-2a cells were transfected with pcNS2B–NS3 or empty vector as described
in Materials and methods. The cells were stained with monoclonal anti-His and then by Rhodamine-conjugated anti-mouse secondary antibody and analyzed under
confocal microscopy. The cells were counterstained with DAPI (a) to highlight the nuclear content of the cells. WNV gene product is visualized in the cytoplasmic
regions forming extensive cytoplasmic vacuolations and blebbings (b). The transfected cell is arrow-marked to indicate corresponding nuclear (a) and cytoplasmic
regions (b). Mock-transfected cells did not yield a specific pattern of staining with the use of the same set of antibodies (c–d).
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proapoptotic construct, pBax caused 40.5% cell death and the
mock-transfected sample resulted only to 5.2% cell death.
Thus, the expression of NS2B–NS3 resulted in rapid cell
death, as observed with pBax-transfected cells (Fig. 2A).Binding of annexin-V to phosphotidylserine in the outer cell
membrane is considered as an early marker of apoptosis. We
employed this tool to determine whether the cell-death induced
by NS2B–NS3 is triggered by apoptosis. Forty-eight hours
after transfection, 30.6% of the RD cells expressing NS2B–
Fig. 2. Induction of apoptosis by WNV NS2B–NS3 complex. (A) RD cells were transfected with h-galactosidase plasmid and empty vector or plasmids expressing
NS2B–NS3 or Bax (proapoptotic positive control). Cells were fixed after 72 h, stained for h-galactosidase expression and the percentage of cell death was
determined. The data are the average of three experiments and standard deviations are indicated. (B) Annexin-V staining of transfected cells. Transfected cells were
assayed for Annexin V staining by flow cytometry 48 h after transfection as described in Materials and methods. (C) TUNEL-assay in Neuro-2a cells. Neuro-2a
cells, grown in two-well chamber slides, were transfected with empty vectors or plasmids expressing NS2B–NS3 or Bax. The cells were fixed at 48 h after
transfection with 4% paraformaldehyde and incubated with TUNEL-reaction mixture. Elevated level of TUNEL-positive cells is revealed in cells transfected with
Bax (a) or NS2B–NS3 (b) expressing constructs. About 2.1% of cells were TUNEL-positive from mock-transfected (c) controls. Representative data of three
independent experiments are shown here.
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transfected cells showed 29.1% staining and the mock-
transfected cells showed only 5.8% Annexin-V staining. Thus,
it was clear that cell death induced by NS2B–NS3 expression
was primarily due to the induction of apoptosis.
Further, NS2B–NS3-expressing cells were subjected to
morphological and biochemical assays to clarify the cytopathic
effects induced by the NS2B–NS3 gene complex. Since
neuronal cells are the critical targets of WNV infection, we
evaluated the ability of WNV gene complex to induce
apoptosis in transfected Neuro-2a cells. Transfected cells were
subjected to TUNEL-staining (Terminal deoxynucleotidyl
transferase-mediated dUTP nick-labeling) of free 3V-OH ends
of cellular DNA to identify the cells with fragmented nuclear
DNA (i.e. apoptotic nuclei). Neuro-2a cells were transfected in
chamber slides and subsequently analyzed by TUNEL assay 48
h after transfection. 28.2% and 27.3% of the transfected cells
were TUNEL-positive from pNS2B–NS3- and pBax-trans-
fected slides, respectively. In mock-transfected slides, only
2.1% cells were positive for TUNEL staining (Fig. 2C). Thus,
the expression of NS2B–NS3 complex raised the percentage of
TUNEL-positive cells. Furthermore, by using a DNA-frag-
mentation assay, the formation of 180 to 200-bp ladder-likeDNA fragments that are characteristic of the apoptotic process
was observed from NS2B–NS3 as well as Bax-transfected
cells (data not shown). The mock-transfected control cells did
not exhibit this specific pattern of ladder formations. These
data confirmed the study of Shrestha et al. (2003). Taken
together, experimental results indicate that the expression of
WNV NS2B–NS3 induced the mammalian cells to undergo
apoptosis resulting in the death of the transfected cells.
Ultra-structural analysis of apoptotic cells expressing
NS2B–NS3 complex
Electron microscopy was performed on NS2B–NS3-trans-
fected RD, Vero and Neuro-2a cells to visualize the changes
induced at the ultrastructural level. In the mock-transfected
cells, clear nuclear and cytoplasmic compartments were seen
with intact organellar constituents (Fig. 3A) including intact
nuclear membranes. In NS2B–NS3-expressing cells, nuclear
degeneration and multiple chromatin bodies were noted (Figs.
3B–D). Figs. 3B and C exhibit further details on the extensive
cytoplasmic vacuolations and membrane blebbings observed as
a consequence of NS2B–NS3 complex expression. In particu-
lar, the loss of nuclear membranes and complete distortion of
Fig. 3. Electron microscopic evidence for the NS2B–NS3-induced apoptosis. Panel A shows the morphology of a representative healthy cell from the slides
transfected with empty plasmid vehicle. An intact nuclear envelope including a nucleolus and an clear outer membrane are visible. Panels B and C exhibit extensive
vacuolations (white-head arrow) in the cytoplasmic areas in NS2B–NS3-transfected cells. Black arrows indicate the loss of plasma membrane integrity and
membrane blebbing of the cells. Panel D indicates a cell that had advanced to the lytic stage with disintegrated nuclear and chromatin materials. Similar results were
observed in multiple experiments.
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NS2B–NS3 complex (Fig. 3D). These morphological char-
acteristics of cell death are consistent with the induction of
apoptotic cell death.
NS3 is sufficient to induce apoptosis in mammalian cells
During the WNV life cycle, NS2B acts as a cofactor for
NS3 protease during the proteolytic processing precursor
polyprotein, as documented in other closely related flavi-
viruses (Amberg and Rice, 1999; Falgout et al., 1991).
However, with regard to the cytopathic effects, it is unclear
in WNV whether NS2B is essential as a cofactor for NS3 to
induce the observed apoptotic effect in cells. In order to
investigate whether NS2B is essential for the apoptotic
process, the open reading frames of these two antigens were
individually cloned into separate mammalian expression
vectors (Figs. 4A and E). Both constructs were validated
for their expression both in vitro and in vivo. Immunopre-
cipitation of radiolabeled in vitro translated gene products
using anti-His antibody, yielded single band with apparent
molecular weight of approximately 14 kDa and 65 kDa for
NS2B and NS3, respectively (Figs. 4B and F). Subsequently,
Neura-2a cells were transfected with NS2B or NS3
expression plasmids and their expression was confirmed by
Western blot analysis. Detection of these proteins as distinctbands appropriate to their molecular mass from the lysates of
these transfected cells supported the expression of these two
WNV antigens in Neuro-2a cells (Figs. 4C and G). The
immunofluorescent studies illustrate that NS2B expression
exhibits a solid and diffuse cytoplasmic staining pattern (Fig.
4D; a and b). NS3 expression yielded a pattern similar to
that of the observations from NS2B–NS3 expression (Fig.
4H; c and d).
The cell viability assay indicated that the expression of
NS2B did not significantly reduce the number of viable cells as
compared with the vector-transfected controls. However, the
level of cell death was almost equal between the plates
transfected with NS2B–NS3 and the NS3-expressing con-
structs. About 44% and 41.5% cell death were caused by
NS2B–NS3 and NS3 expression plasmids, respectively (Fig.
5A). Annexin-V assay was also carried out to distinguish the
effects induced by NS2B and NS3. At 48 h post-transfection,
over 30.6% of cells were positive for annexin-V staining from
the NS2B–NS3-transfected cells, while NS3 expression alone
yielded 26.7% Annexin V staining. However, the levels of
annexin-V-positive cells from NS2B-expressing cells (8.9%)
were apparently closer to the level observed from the mock-
transfected (6.5%) controls (Fig. 5B). Additionally, ladder-like
degenerating DNA fragments were observed only from the
plates transfected with NS3 and the NS2B–NS3 complex and
not from the cells transfected with the vector or the plasmid
Fig. 4. Cloning and expression of WNV NS2B and NS3 antigens. (A–D) Expression analysis of NS2B. Panel A shows the diagrammatic map of pcNS2B and the
fragment size of NS2B. Panel B shows autoradiographic image of immunoprecipitated and radiolabeled product of in vitro translated NS2B with the mass of 15.0
kDa, as described in Materials and methods. (C) Western analysis of NS2B expression in Neuro-2a cells. The lysates of vector or pcNS2B-transfected cells were
immunoprobed against anti-His antibody. (D) Localization of NS2B. Neuro-2a cells transfected with empty vector or NS2B were fixed at 36 h after transfection,
stained with anti-His antibody followed by FITC-conjugated anti-mouse secondary antibody and counterstained with DAPI. Diffused cytoplasmic expression of
NS2B (b) is arrow-marked. (E–H) Expression analysis of NS3. Panel E describes pcNS3 plasmid with a fragment size of 1861 bp in length. Panel F indicates an
autoradiographic image of in vitro analysis of 63 kDa-NS3 from pcNS3. (G) Western blot analysis of Neuro-2a cells transfected with empty vector or pcNS3. Actin
was used as internal control. Panel H shows the vesicular and blebbing pattern around the nucleus of a NS3-expressing cell (d). The upper panel (c) indicates the
counterstaining of cells with DAPI. As described above, pcNS3-transfected cells were incubated with anti-His primary antibody and FITC-conjugated anti-mouse
secondary antibody.
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confirm that only the expression of NS3 led to the induction of
host cell apoptosis but not NS2B. Thus, in WNV, NS3 is not
dependent on the expression of NS2B for the induction of the
apoptotic pathway in the transfected cells.NS3, but not NS2B expression triggers caspase-3 activation
Activation of caspase-3 which acts as an effector caspase
represents a cross-road for several apoptotic pathways,
regardless of the source of activation by effector caspases.
Fig. 6. Caspase-3 activation due to the expression of WNV gene products. (A
RD cells were transfected with vector or plasmids expressing NS2B–NS3 o
NS3 or NS2B. At 60 h after transfection, the cells were lysed and the lysates
were used for the determination of caspase-3 activity using colorimetric assay
The release of chromophore-conjugated caspase-3 substrate due to the specific
action of caspase-3 was measured at 405 nm. The data are normalized and the
standard bars are derived from triplicate samples. Panel B indicates the Western
blot analysis of these lysates against anti-p17 fragment of activated caspase-3
using monoclonal anti-caspase-3 antibody that detects only activated p17
fragment (upper panel). Similar results were obtained from multiple experi
ments. Anti-actin antibody (lower panel) was used as an internal control.
Fig. 5. NS3 alone is sufficient to induce apoptosis. (A) As described in legend
2, RD cells were transfected with h-galactosidase plasmid and empty vector or
plasmids expressing NS2B–NS3 or Bax (proapoptotic positive control). They
were fixed after 72 h, stained for h-galactosidase expression and the percentage
of cell death was determined. (B) Annexin-V staining of transfected cells
concurs with the viability assays. Empty vector or pcNS2B–NS3 or pcNS3 or
pcNS2B-transfected cells were assayed for Annexin V staining by flow
cytometry at 48 h after transfection. The experimental results shown are
representative of three independent experiments.
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by NS3. Both colorimetric and Western analysis of lysates of
transfected cells confirmed the induction of caspase-3 activi-
ties. Fig. 6A shows an elevated level of caspase-3 activity from
the cells transfected with either the NS2B–NS3 or the NS3
expression plasmids. Whereas, the level of caspase-3 activation
in NS2B-expressing cells was almost closer to the level
observed from the negative control samples. The lysates of
these transfected cells were also immunoblotted using anti-
caspase-3 antibody that specifically detects only the activated
p17-fragment of caspase-3. Western blot analysis supported the
presence of the activated p17 fragment only in NS2B–NS3-
and NS3-transfected cell lysates. The lysates from NS2B-
transfected as well as negative controls were negative for the
detection of this activated caspase-3 fragment (Fig. 6B). These
results together illustrate that the recruitment of apoptotic
pathways targeting caspase-3 is induced in NS2B–NS3 and
NS3-expressing cells and not in the NS2B expressing cells.
Inhibition of NS3-induced apoptosis by specific caspase
inhibitors
To identify the initiator caspase upstream of the caspase-3
step, we evaluated the ability of WNV NS3 gene to induceapoptosis following treatment with specific caspase inhibitors.
The cells were transfected with NS3 expression plasmids and
they were monitored under the influence of these cell-
permeable inhibitors of caspase-3 (DEVD-CHO), -8 (IETD-
CHO), -1 (YVAD-CHO) and -9 (LEHD-CHO). Prior to the use
of these caspase inhibitors in this study, the specific inhibitory-
action of these reagents was confirmed using appropriate kits
with suitable substrates (Calbiochem) in a pilot study (data not
shown). The viability of transfected cells was determined for
72 h in the presence or absence of various concentrations of
caspase inhibitors (Fig. 7). Interestingly, caspases-8 and -3
inhibitors significantly prevented cell death induced by NS3
expression. In contrast, the addition of caspases-1 and -9
inhibitors to the NS3-transfected cells did not appear to be very
effective on the cytopathic effects induced by NS3 expression,
Approximately 28.0% and 29.9% of cell death were observed
in the presence of caspases-9 or -1 inhibitors, respectively.
About 32.6% of cells were depleted from the NS3-transfected
plates that were not treated with any of these inhibitors.
Interestingly, inhibitors of both caspases-3 and -8 prevented
cell death induced by NS3. Though this difference is modest,
caspase-8 inhibition exerted more potent effect (10.1% cell
death) than that of the caspase-3 inhibitor (12.7%) (Fig. 7A).
The lysates of these cells were also analyzed for the verification)
r
.
-
-
Fig. 7. Effect of cell permeable caspase inhibitors on NS3-induced cell death.
(A) The level of cell death due to the expression of NS3 was monitored under
the influence of cell permeable inhibitors that selectively inhibit caspase-1, or
-3 or -8 or -9. The values of percent cell death at the time 60 h after
transfection were plotted. The resulting data are the mean of triplicates with
standard errors. (B) Transfected cells were also analyzed by Western analysis to
validate the expression of NS3 under the influence of these caspase inhibitors.
The upper panel confirms an identical level of expression of NS3 and the
bottom panel shows the level of actin as an internal control. The experimental
results shown are representative of three independent experiments.
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inhibitors. Immunoblotting of these samples against anti-His
antibody confirmed that the caspase inhibitors did not exert any
effect on the expression of NS3 (Fig. 7B). These results suggest
that NS3 expression is linked to an apoptotic pathway mediated
either individually or together by caspase-8 and caspase-3.
NS3 interacts with procaspase-8 and cleaves it into active
forms
The experimental results from the use of caspase-8 (IETD-
CHO) and -9(LEHD-CHO) inhibitors indicated that caspase-
8 appeared to be an initiator caspase in the cells expressing
NS3. To test this, we sought to examine whether NS3
physically interacts with procaspase-8 and cleaves it further
into its active subunits such as p43/41, p18 and p10. Interaction
between NS3 and the procaspase-8 was tested by an
immunofluorescent assay using procaspase construct that
encodes HA-tagged procaspase-8. NIH 3T3 cells were
cotransfected with both NS3 and HA-caspase-8 expression
plasmids. The overlay of the images in Fig. 8A(d) suggests that
NS3 and HA-caspase-8 colocalized in the same location in the
cytoplasm of the cells. Use of either anti-His or anti-HA
antibodies in the mock-transfected cells did not yield any
specific signals, thus demonstrating their specificity in this
assay. Further, the lysates from NS2B, NS3, NS2B–NS3 or
mock-transfected cells were immunoprobed using monoclonalanti-caspase-8 antibody to detect whether NS3 expression leads
to the activation of the caspase-8 molecule. In NS2B and
mock-transfected samples, the procaspase-8 molecule remained
uncleaved. Interestingly, in NS2B–NS3- and NS3-transfected
cells, the level of procaspase-8 appeared to be diminished
almost completely and elevated levels of activated molecules
were noted. These intermediate activated species were mostly
absent in NS2B and mock control samples. Further, we
observed the bands that corresponded to p18-fragment of
activated caspase only in the lanes representing NS3 and
NS2B–NS3 (Fig. 8B). These results support that WNV NS3
interacts with the initiator caspase-8 molecule and activates its
further cleavage into active intermediate proteins.
Ablation of caspase-8(by siRNA) rescued NS3-induced
apoptosis
Additionally, to investigate whether activation of caspase-
8 upon the expression of NS3 was important in inducing
apoptosis in NS3-expressing cells, we sought to ablate caspase-
8 levels using siRNA. Vero cells were transfected with
plasmids expressing NS3 and caspase-8 siRNA expression
vector (pGB-Casp-8) or control siRNA vector (pGB-control).
pGB-control vector with a siRNA sequence that has no
homology to mammalian genes was used here as a negative
control. Transfection with caspase-8 siRNA, not pGB-control
specifically reduced the level of NS3-mediated cell death.
Transfection with caspase-8 siRNA prevented NS3-induced
apoptosis in vero cells as evident from the viability assays (Fig.
9A). Further, the level of caspase-8 (Fig. 9B) and caspase-3
(Fig. 9C) activities was significantly reduced in the cells
expressing NS3 and caspase-8 siRNA together as evident from
the caspase-specific colorimetric assays. This study, in line
with the use of caspase-inhibitors, established that caspase-
8 activation was essential for WNV-NS3 induced apoptosis.
Expression of NS3 leads to nuclear herniations and
Poly(ADP-ribose) polymerase cleavage
The involvement of caspase-3 activation in the NS3-
expressing cells, prompted us to investigate the recruitment
of other cellular proapoptotic proteases and DNA repair
enzymes by NS3. We examined if nuclear membrane ruptures
are associated with the expression of NS3 as it has been
reported in other viral apoptotic systems (de Noronha et al.,
2001). Costaining for the detection of both NS3 expression and
the integrity of nuclear membrane (using monoclonal anti-
nuclear pore complex antibody) revealed that the cells
expressing NS3 alone exhibited nuclear ruptures consistent
with this hypothesis (Fig. 10A; a–h). Interestingly, nuclear
rupture was blocked in most of the NS3-expressing cells that
were treated with the caspase-3 inhibitor, DEVD-CHO (Fig.
10A; i–p). Mock-transfected and untransfected cells did not
display any ruptures in their nuclear envelopes (data not
shown). These herniations were associated with defects in the
nuclear lamina. These studies place the nuclear herniations
downstream of caspase-3 activation by NS3. Poly(ADP-
Fig. 8. Activation of initiator caspase-8 by NS3. (A) NS3 physically interacts with HA-caspase-8. HeLa cells, grown in chamber slides, were cotransfected with NS3
and HA-caspase-8 expressing plasmids and analyzed in immunofluorescent microscopy. The cells were incubated with monoclonal anti-His (for NS3)- and
polyclonal anti-HA antibodies. Subsequently, they were treated with anti-mouse-rhodamine- and anti-rabbit-FITC-conjugated secondary antibodies. DAPI was used
to counterstain the nuclear content of the cells to visualize the nuclei of the cells (a and e). The overlay of the images from rhodamine (NS3) and FITC (HA-caspase-
8) panels clearly illustrates the colocalization of these two proteins (d and h). (B) NS3 activates the cleavage of procaspase-8. Equal amounts of the lysates from
vector or plasmids encoding NS2B or NS2B–NS3 or NS3 were resolved by SDS-PAGE and immunoprobed against anti-caspase-8 antibody as described in
Materials and methods. Arrows indicate specific bands of procaspase-8 and proteolytic products such as p43/41 and p18. Equal loading of samples was verified by
probing with anti-actin antibody. Similar results were obtained in multiple experiments.
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is one of the earliest proteins targeted by caspases such as
caspases-3, -7 and -9. During apoptosis, caspase-3 cleaves the
PARP (116 kDa-protein) into a 81-kDa protein. The appear-
ance of this cleaved p81-fragment is an evidence for the
activation of PARP. Cleavage of PARP in the NS3-complex-
transfected cells was examined by using Western blot analysis.
In this study, the cleaved PARP p-81 fragment was observed
from both NS3-expressing and Bax-expressing cells which
served as the positive control (Fig. 10B). Absence of p81-
fragment from the mock-transfected samples demonstrates that
cleavage of PARP was specifically noted in the NS3-expres-
sing cells.
EM analysis of cells expressing NS2B or NS3 or NS2B–NS3
In order to confirm at the ultra-structural level that the
apoptotic cell death is induced by the expression of only NS3
and not by NS2B, the transfected cells expressing individually
NS2B or NS3 or NS2B–NS3 complex were subjected to
electron microscopic analysis. In line with other experimental
results, only NS3- and NS2B–NS3-transfected cells displayed
typical apoptotic manifestations such as extensive vacuola-tions, total collapse of nuclear membrane and chromatic
disintegrations (Figs. 11C and D). Vector as well as NS2B-
transfected samples (Figs. 11A and B) did not exhibit any cells
that underwent apoptotic cell death. However, in NS2B
expressing cells, we observed higher frequency of blebbings
from the outer plasma membrane surface (Fig. 11B) and
biological relevance of this finding is unclear at this point. But
these extensive blebbings (Fig. 11B) were not pinched off of
the cells with any of the cytoplasmic inclusions resembling the
case of NS2B–NS3-transfected cells (Fig. 11D).
Both protease and helicase domains of NS3 are critical for
apoptotic induction
In order to map the domains that are critical for apoptotic
induction by NS3, a panel of WNV NS3 mutants was
constructed as indicated in the Fig. 12. An analysis of the
radiolabeled protein samples generated from these mutants
using cell-free translation system confirmed the generation of
appropriate mutant products corresponding to the length of
their open reading frames (Fig. 12B). NS3 mutants were
screened for their ability to induce host cell death. At 60 h,
after transfection, the full-length NS3 resulted in 29.3% cell
Fig. 9. siRNA-caspase-8 blocks the activation of caspase-8. (A) Cells were
transfected with plasmids expressing NS3 and caspase-8 siRNA expression
vector (pGB-Casp-8) or control siRNA vector (pGB-control). The transfected
cells were subjected to viability assays and caspase-specific colorimetric
assays. Panel A shows that the caspase-8 siRNA significantly prevents the cell
death induced by NS3. The viability was assessed and values of percent death
observed at 60 h after transfection. Lysates were prepared from these cells and
subjected to caspase-8 and caspase-3 activities measured by colorimetric assay.
Panels B and C confirm the blockage of activation of caspase-8 and caspase-3,
respectively, triggered by NS3 expression. PGB-control vector did not affect
the NS3-induced cell death activities. The resulting data are the mean of
triplicates with standard errors.
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death in the transfected cells and thus slightly more than the
full-length molecule. Comparatively, the expression of the
mutants NS3(1–350) and NS3(1–460) is ineffective in
arresting cell proliferation as evidenced from the observation
of 15.4 and 16.0% cell deaths induced by them, respectively.
Interestingly, the over-expression of the mutant (278–619)
significantly reduced the survival rate of the cells. 24.7% cell
death was induced by this mutant, which was almost equal to
the effect of the full-length molecule. The ability of the
mutants (350–619) and (450–619) to induce cell death was
completely blocked (Fig. 13). The apoptotic potential of the
protease-coding domain is similar to the observations made inanalysis of other closely related flaviviruses (Prikhod’ko et
al., 2002; Shafee and AbuBakar, 2003). However, it is
surprising that the mutant (278–619) was also effective in
impacting cell viability. Mutant (278–619) represents an
intact portion of the helicase domain. These data together
suggest that independent expression of intact protease or the
helicase domain could play a role in WNV-induced cell death.
However, the expression of NTPase domain appears to have
negligible effect on host cell survival. Thus, it is clear in the
case of WNV that, unlike other studied flaviviruses, multiple
domains in WNV NS3 mediate apoptosis in mammalian cells.
Recently, it has been shown in HCV that NS3 could induce
apoptosis independent of protease and helicase domains
(Prikhod’ko et al., 2004).
Discussion
Several different RNA viruses have been reported to induce
apoptosis. Among flaviviruses, DENV (Despres et al., 1996,
1998; Duarte dos Santos et al., 2000), WNV (Chu and Ng,
2003; Parquet et al., 2001b; Yang et al., 2002), SLEV (Parquet
et al., 2002), JEV (Liao et al., 1997), Langat (Prikhod’ko et al.,
2001, 2002) and TBEV were shown to drive host cell death via
apoptotic pathways. RNA viruses are thought to induce
apoptosis to facilitate the release of virions from cells for
facilitating rapid spread of inspection. Programmed cell death
may support viral progeny dissemination while limiting
induction of inflammatory and immune responses (Teodoro
and Branton, 1997). Apoptosis is an active and highly
conserved process of cellular self-destruction with distinctive
morphological and biochemical features. Many viruses have
evolved genomes encoding proteins that effectively suppress or
delay apoptosis and consequently maintain host survival during
replication for the production of sufficient higher quantities of
progeny. Thus, host cell death by viral pathogens depends on
both viral and host cell factors. Virus-driven host cell apoptosis
is considered to be important in host pathogenesis and
understanding of viral factors that induce cell death is
important. In this report, we provide evidences for the
induction of host cell death induced by a non-structural gene
of WNV virus, NS3.
The proteolytic role of NS2B–NS3 in processing WNV
polyprotein has been well documented (Yamshchikov and
Compans, 1993, 1994). In the present study, an additional role
has been demonstrated for this proteolytic complex in the
context of host cell killing by WNV. Here, we show that the
expression of NS2B–NS3 in the absence other WNV genes
could lead to the rapid cell death. This complex drives the
induction of cell membrane blebbing and convolulation,
cytoplasmic vacuolations, nuclear membrane rupture and
chromatin disintegration. These apoptotic manifestations were
recently shown in WNV-infected cells (Shrestha et al., 2003).
Immunofluorescent studies on the expression of NS2B–NS3
cassette revealed a cytoplasmic distribution pattern for this
complex; this is in line with the observations made from other
Flaviviral NS2B–NS3 complex (Prikhod’ko et al., 2002;
Shafee and AbuBakar, 2003). When individually expressed,
Fig. 10. Induction of nuclear envelope herniations and PARP cleavage induced by NS3 expression. (A) NS3-transfected cells, with or without the treatment of
caspase-3 inhibitor, were costained for visualizing the expression of NS3 as well as the integrity of nuclear envelope. Anti-His primary and rhodamine-conjugated
secondary antibodies were used for detecting NS3 expression. Monoclonal anti-NPC complex and FITC-conjugated secondary antibody were used to stain the
nuclear membrane. In the left panel (a–h), the NS3-expressing cells display ruptured nuclear membrane. In the right panel, the NS3-transfected cells were
maintained under the influence of cell-permeable caspase-3 inhibitor. This panel shows that the nuclear membrane rupture is almost absent in the NS3-expressing
cells as highlighted in the overlay panel (i and p). The NS3-expressing cells are arrow-marked. (B) PARP cleavage in NS3-expressing cells. Cleavage of 114-kDa
PARP is one of the commonly observed effects of the activation of caspase-3-based apoptotic pathways. RD cells were transfected with vector or plasmids
expressing NS3 or Bax. The lysates of transfected cells were immunoblotted using anti-PARP antibody as described in Materials and methods. Western analysis
indicates the cleavage of PARP in NS3- and Bax-transfected cells (B). The experiments results shown are representative of multiple independent experiments.
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localization patterns. While NS3 expression is expressed as
clusters and vesicular structures in the perinuclear area, NS2B
exhibits a more diffuse pattern in the cytoplasm. In other
Flavivirus systems, NS2B acts as a cofactor and binds to NS3in vivo to form a proteolytic-complex, which is essential for the
proteolytic processing of the polyprotein (Falgout et al., 1991,
1993). Thus, NS3 depends on NS2B to perform its proteolytic
function for the advantage of virus life cycle (Chambers et al.,
1990b, 1991; Lobigs, 1992; Preugschat et al., 1990; Pugachev
Fig. 11. Electron microscopic analysis on NS3-induced apoptotic cells. Vector-transfected or pcNS2B or pcNS3 or pcNS2B–NS3-expressing Neuro-2a cells were
analyzed for electron microscopy as described in Materials and methods. Panel A reveals a representative healthy cell from the mock-transfected control. Panel B
shows a magnified view of cells that highlights an elevated level of membrane blebbings from the outer plasma membrane. Panel C shows a typical nuclear
degeneration and chromatin condensation in NS3-expressing cells. Similar nuclear condensations were not observed with NS2B-transfected cells. Panel D represents
an apoptotic cell from pcNS2B–NS3-transfected samples. This cell exhibits onset of chromatin condensation (black-head arrow) and blebbing out of highly
vacuolated cellular contents and vesicular structures from its membrane surface (white-head arrow).
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critical properties of NS3 such as NTPase and helicase
activities do not require the dependence on NS2B. For example
in YFV, NTPase activity of NS3 (Warrener et al., 1993) is
independent of its association with NS2B (Droll et al., 2000).
Experimental results from this study prove that that WNV NS3
alone can induce host cell apoptosis, independent of its
association with NS2B.
WNV NS3 alone was able to induce apoptotic manifesta-
tions such as nuclear herniations, cell vacuolations and
blebbing in the transfected cells. NS3 expression initiated the
activation of caspase-8, which in turn triggers the activation of
effector caspase such as caspase-3. The use of cell-permeable
caspase inhibitors such as and IETD-CHO and DEVD-CHO
that are specific to caspases-8 and -3, respectively, confirmed
the participation of these caspases in the observed apoptotic
process. An overview on the apoptotic pathways suggests that
caspase-8- and caspase-9-based pathways are distinct from one
another. However, there are several papers supporting theexistence of cross effecting of these pathways (Fadeel et al.,
2000; Rossi and Gaidano, 2003). In the case of NS3-induced
cell killing, caspase-8 appeared to be independent of the
activation of caspase-9 as the caspase-9-inhibitor failed to
prevent NS3-induced apoptosis. Experimental results from the
use of caspase-8 siRNA demonstrated that the activation of
caspase-8 is essential in NS3-expressing cells for triggering
cascade of apoptotic signaling leading to the cell death. A
recent study demonstrated the involvement of multiple path-
ways during apoptotic cell death caused by WNV-infection
(Chu and Ng, 2003). Recruitment of caspase-8 by NS3 was
reported from a distantly related virus, Langat virus (Pri-
khod’ko et al., 2002). An initial report on WNV infection-
induced cell death illustrated the activation of bax-expression,
which underlines a caspase-9-based mitochondrial-mediated
pathway (Parquet et al., 2001b). Subsequently, the culprit gene
that mediates the mitochondrial-based pathway in the host cell
death was found to be the capsid gene in WNV (Yang et al.,
2002). Considering the severity as well as the rate of cell
Fig. 12. (A) Deletion mutagenesis of NS3. (A) Schematic representation of NS3 mutants used in this study. The deletion mutants were constructed to encode different
domains of NS3 and referred by their corresponding amino acid numbers. (B) The autoradiographic image of in vitro translated mutants. The molecular mass of these
proteins corresponds to the length of their open reading frames. The generation and analysis of in vitro translated and radiolabeled proteins samples are described in
Materials and methods. The immunoprecipitated products are arrow-marked.
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participate in induction of the apoptotic cascade during this
viral infection.
Downstream of the caspase-3 activation step, rupture of
nuclear envelope and disintegration of nuclear contents by
DNA repair enzymes contribute to the ultimate disintegration
of the apoptotic cell. In NS3-expressing cells, we showed theFig. 13. Both protease and helicase domains mediate cytopathic effect of NS3. Ver
viability of these transfected cells was monitored by dye-exclusion method. The fi
resulting data are the mean of triplicates with standard errors.nuclear rupture that could possibly be due to the activation of
caspase-3. The inability of this antigen to induce a similar
damage in the nuclear membrane under the influence of
caspase-3 inhibitor supports this finding. Besides the rupture of
nuclear membrane, this study also identified the cleavage of
PARP in the lysates of NS3-transfected cells. This observation
concurs with a recent study illustrating PARP cleavage fromo cells were transfected with vector or plasmids expressing NS3 mutants. Cell
gure indicates percent death of transfected cells at 60 h after transfection. The
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the specific protein of WNV that is responsible in the PARP
cleavage.
Mutational analysis of NS3 yielded surprising results. Since
the protease domain is a vital part of the NS2B–NS3 complex,
it was anticipated that this same domain would determine
apoptotic phenotype of this molecule. A NS3 mutant (1–190)
that represents the proteolytic domain alone was sufficient to
induce apoptosis. This concurs with an earlier report on TBEV
NS3 in which protease domain alone mediated the apoptotic
induction. In the case of WNV NS3, an intact helicase domain
encoded by the mutant (278–619) also appears to cause
apoptosis as evidenced in Fig. 13. Therefore, the over-
expression of NS3-helicase domain alone is sufficient to induce
cell death. However, the relevance of these proteolytic and
helicase activities to WNV pathogenicity is yet to be addressed
in detail. The expression of the NTPase domain (278–460)
failed to arrest cell proliferation. Thus, over-expression of
NTPase domain is not fatal to these transfected cells, though
other metabolic effects of this component may not be ruled out.
In summary, this is the first report that demonstrates the
typical apoptotic manifestations such as cytoplasmic vacuola-
tions and membrane blebbings, chromatin disintegration and
complete lysis of cells, procaspase-8 cleavage and subsequent
caspase-3 activation, and nuclear membrane rupture and
PARP-cleavage from WNV NS3-transfected cells. Also,
NS3-induced apoptotic cell deaths were shown in multiple
cell lines such as HeLa, RD, NIH 3T3, Neuro-2a and Vero
cells. Therefore, host cell killing by NS3 is not cell-specific. It
is notable that WNV multiplies in divergent cell types,
subsequently resulting in cell death (Monath and Heinz,
1996; Odelola and Fabiyi, 1977; Shahar et al., 1990). Several
viruses induce host cell death via apoptosis (Marianneau et al.,
1997; Teodoro and Branton, 1997) through divergent path-
ways. However, the pathways used by viruses for the induction
of apoptosis appear very complex. In this report, we have
clarified a pathway recruited by NS3 to drive host cell death.
Further characterization of the programmed cell death path-
ways triggered by NS3 will expand our understanding about
the mechanistic insights into WNV pathogenesis. It will be
interesting, if NS3-induced apoptosis offers benefits to the viral
life cycle beyond the level of host cell lysis. Currently, host cell
apoptotic pathways activated by viral pathogens have received
much attention as they provide immense value for targeted
therapy. A thorough knowledge on the apoptotic pathways
driven by NS3 as well as WNV itself will undoubtedly provide
valuable insight for the development of novel therapeutics for
this viral infection.
Materials and methods
Cell lines and culture conditions
Cell lines including NIH 3T3, Neuro-2a, SH-SY5Y, RD,
HeLa and Vero were obtained from ATCC (Manassas, VA).
Culture media and other standard tissue culture reagents were
obtained from Life Technologies, Inc. (Rockville, MD). NIH3T3 cells were propagated in minimum essential medium
(MEM) with 10% calf serum (Sigma) and 1% Pen/Strep
antibiotic. Mouse neuroblastoma cells were maintained in
antibiotic-free minimum essential medium (MEM) with Earle’s
salts supplemented with 2 mM l-glutamine and 10% fetal
bovine serum. African green monkey kidney cells (Vero) were
grown in minimal essential medium supplemented with 10%
fetal bovine serum, 2 mM l-glutamine, 1% sodium pyruvate
and 1% Pen/Strep. Minimum essential medium (MEM)
supplemented with 10% fetal bovine serum, 2 mM l-
glutamine and 1% antibiotic solutions was used to maintain
HeLa and RD cells.
Cell viability assay
Cell viability was determined by trypan blue exclusion. Cells
were harvested at different intervals post-transfection, resus-
pended in PBS and mixed with an equal volume of 0.1% trypan
blue. The cells plated in a hemo-cytometer chamber that excluded
the dye were counted as live by eye under visual microscopy.
Reagents and plasmids
The mammalian expression vector, pcDNA3.1/His A, h-
galactosidase-His expression plasmid, Top 10F E. coli chem-
ically treated competent cells and anti-His monoclonal anti-
body were purchased from Invitrogen (Carlsbad, CA).
Rhodamine and FITC-conjugated secondary antibodies were
purchased from Roche Molecular Biochemicals (Indianapolis,
IN). Monoclonal anti-NPC antibody (Clone a-414) that stains
the nuclear pore complex was purchased from Abcam.com.
Anti-caspase and anti-poly(ADP-ribose)polymerase (PARP)
antibodies were purchased from Santa-Cruz Biotechnologies.
Caspase assay kits, including caspase-inhibitors and caspase
substrates were purchased from Clontech Laboratories. Horse-
radish peroxidase-conjugated secondary antibodies were pur-
chased from Amersham Pharmacia Biotech Ltd. (Piscataway,
NJ). Cell permeable caspase inhibitors were purchased from
Calbiochem Biochemicals (San Diego, CA). Anti-caspase-3
antibody specific for the activated fragment, p-17 and anti-actin
antibodies are from Sigma Co. (Saint Louis, MO). Gene-
Blocker siRNA vectors (pGB) such as pGB-control and pGB-
caspase-8 were purchased from BioVision Research products
(Mountain View, CA).
Cloning of NS2B, NS3 and NS2B–NS3 complex from the brain
tissues of a WNV-infected bird
From the brain tissue of a WNV-infected dead bird, a total
RNA pool was prepared and used as a substrate to synthesize
cDNA encoding specific WNV genes (Ramanathan et al., in
press). Using this cDNA pool as template, the open reading
frames of NS2B, NS3 and NS2B–NS3 were PCR-amplified.
For cloning NS2B, forward 5V-CGGATCCAACATGGGA-
TGGCCCGCAACTGAAGTG-3V and reverse 5V-GTGTCCC-
ACAACACGCCTCCTCTCTTTGTGTAT-TGGAG-3V primers
were used. Forward 5V-CG-GATCCAACATGGGAGGCG-
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CACGCCTCCT-CTCTTTGTGTATTGGAG-3V were used to
amplify NS3 fragments. NS2B3 forward 5V-CGGATCC-
AACATGG-GAGGCGTGTTGTGGGAC-3V and NS3 reverse
5V-GTGTCCCACAACACGCCTCCTC-TCTTTG-TGTATTG-
GAG-3V primers were used to clone whole NS2B–NS3
complex. The amplified fragments were purified from the gel
and ligated into pcDNA3.1/V5/His vector that adds a
polyhistidine synthetic epitope to the C-terminal end of the
cloned gene product. For NS2B and NS3, a methionine-
encoding start triplet was added appropriately in the Kozak
sequence for maximizing the expression in the mammalian
cells.
Construction of NS3 mutants
The LM strain NS3 clone, pcNS3 was used as a template to
generate FLAG-tagged NS3 mutants. Appropriate Kozak
sequence followed by FLAG-tag was added to the forward
primers used in this part to generate mutants that have FLAG-
epitope at their amino-terminal end. The mutants’ names refer
the corresponding amino acid residues of NS3. The mutants
and their primers used were as follows: NS3(1–190): 5V-
ACCATGGACTACAAGGACGACGACGACAAGGGCG-
TGTTGTGGGACACTCCCTCA-3V and 5V-TCATCAG-
ATCTGTTTTTTCCTCAGCATCTC-3V; NS3(1–350): 5V-
ACCATGGACTACAAGGACGACGACGACAAG-
GGCGTGTTGTGGGACACTCCCTCA-3V and 5V-TCATCAG-
TATCCAGA-GTTCCAAGCTCGATCCGG-3V; NS3(1–460):
5 V-ACCATGGACTACAAGGACGACGACGACAAG-
GGCGTGTTGTGGGACACTC-CCTCA-3V and 5V-TCAT-
CATCCACGTCTCTGGGCGGCACTAGCTG-CTGTCAC-3V;
NS3 (350–619):5V-ACCATGGACTACAGGACGACGAC-
GACAAGGAATGGATCACA-GAATACACCGGGAAG-3V
and 5V-TCATCAACGTTTTCCCGAGGCGAAGTCCTT-
GAACGC-3V; NS3(278–619): 5V-ACCATGGACTACAAG-
GACGACGACGACAAGCCGAACTACAACCTGTTCGT-
GATGGAT-3V and 5V-TCATCAACGTTTTC-CCGAGGC-
GAAGTCCTTGAACGC-3V; NS3 (460–619): 5V-ACCATG-
GACTACAAGGACGACGACGACAAGGGACGTATC-
GGTAGAAATCCGTCGCAA-3V and 5V-TCATCAACGTT
TTCCCGAGGCGAAGTCCTTGAACGC-3V; The resulting
PCR products were cloned and the positive clones were
verified by automated sequencing. Prior to their use in cell
culture studies, the integrity of these constructs was verified by
in vitro expression analysis.
Cell-free translation
TNT coupled Rabbit Reticulocyte in vitro transcription/
translation system (Promega Corporation, Madison, WI) was
routinely employed to generate radiolabeled protein samples
for checking the integrity of the constructs used in this study.
Reactions were run as recommended by the manufacturer
with 2 Ag unlinearized plasmid DNA. Translation products
were labeled by the addition of 1 uCi of [35S]methionine per
reaction and run for 90 min. Translation products wereimmunoprecipitated by using anti-His or anti-FLAG anti-
bodies as per the conditions previously described (Rama-
nathan et al., 2002) and analyzed on SDS-PAGE with imaging
by fluorography.
Confocal microscopy
Cells were seeded onto slide chambers (Beckton-Dick-
enson, Franklin Lakes, NJ) overnight prior to their use in
transfection studies. Transfection was routinely carried out
using DOTAP transfection reagent (Roche Molecular Diag-
nostics, Piscataway, NJ). The cells were fixed on slides using
methanol and incubated with the primary antibodies for 90
min. The primary antibodies were removed by gentle rinsing
with PBS. The slides were then incubated with the FITC and/
or Rhodamine-conjugated secondary antibodies (Roche Mo-
lecular Biochemicals) for 45 min. DAPI (Sigma, St. Louis,
MO) was added to the solution of secondary antibodies to
counterstain the nuclei in order to show nuclei of total
number of cells available in the given field. The slides were
mounted with mounting media containing anti-fading reagent
(Molecular Probes, Inc, Eugene, OR) (Ramanathan et al.,
2002) and the images were obtained using a Zeiss LSM
confocal microscope.
Terminal deoxynucleotidyl transferase-mediated dUTP
nick-end labeling (TUNEL) assay
Transfections were carried out in the chamber slides as
described above. Forty-eight hours post-transfection, the cells
were fixed with 4% paraformaldehyde and treated with
TUNEL reaction mixture as per the manufacturer’s protocol
(Roche Molecular Biochemicals). The cells were subsequently
mounted with anti-fade mounting medium and analyzed under
fluorescent microscopy.
Western blot analysis of transfected cell lysates
One million cells were seeded in 100 mm tissue culture
dishes on the day prior to transfection. The cells were
transfected with 5 Ag of study plasmids using DOTAP (Roche
Molecular Biochemicals) according to the manufacturer’s
protocol. The transfected cells were lysed using a lysing buffer
(Pierce Biochemicals, Rockford, IL) containing protease-
inhibitor cocktail (Roche Molecular Biochemicals). The lysates
were resolved in SDS-PAGE (Fisher Biochemicals) and
electroblotted onto PVDF-membranes [Immobilon-P-polyvi-
nylidene difluoride (Millipore, Bedfore, MA)] using standard
reagents and procedures. The protein blots were incubated with
appropriate primary antibodies for 2 h, washed and incubated
with HRP-conjugated secondary antibodies for an hour. After
rinsing, the blots were developed with the ECL-Plus Chemi-
luminescent detection Kit (Amersham Biosciences, Buckin-
ghamshire, UK). Stripping of antibodies from membranes after
the ECL reaction was performed using Western blot stripping
buffer (Pierce Biotechnology Inc., Rockford, IL) as per the
instructions provided by manufacturer. Anti-actin antibody
M.P. Ramanathan et al. / Virology 345 (2006) 56–72 71(Sigma Biochemicals, St. Louis, MO) was used as an internal
control for the immunoblots.
Flow cytometry determination of annexin-V staining
For determination of apoptotic potential of WNV gene
constructs, the transfected cells were gently scrapped from the
plate surface and resuspended with VERSENE, washed twice
in 1 PBS. Annexin-V (BD Biosciences) was added to the
cells as per the manufacturer’s protocol and incubated for 15
min. The cells were washed extensively with 1 PBS and
analyzed directly on a Coulter EPICS Flow Cytometer.
Immediately prior to analysis, Propidium Iodide (0.5 Ag/ml)
(Sigma, St Louis MO) was added to each sample. About 104
cells were counted in each assay.
Ultrastructural studies
Cells were transfected with NS3, NS2B–NS3 or NS2B or
vector backbone plasmids in 6-cm plates as described in other
sections. Two days after transfection, cells were harvested from
the plates, washed with cold PBS and fixed with 2.5%
glutaraldehyde and 2% formaldehyde. Cells were then post-
fixed for 90 min at 4 -C in 1% osmium tetroxide. A series of
ethanol dilutions of increasing concentration were used to
dehydrate the samples before embedding in low-viscosity resin.
Ultrathin sections (50–70) stained with 2% uranyl acetate and
post-stained with 2% lead citrate were viewed under a Phillip
electron microscope.
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